cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.30577679.v1
title: Figure 5D-F primary data

description: Figure 5D-F legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”), 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) to block IFN-β paracrine signaling. Protein was isolated from BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i+anti-IFN Abs based on tdTomato expression. Western blots were probed for ATF2, c-Jun, and β-actin as a loading control. Levels of ATF2 and c-Jun in sorted samples were quantified from the western blots, normalized to β-actin, and plotted relative to bulk lytic+casp-i+ anti-IFN Abs samples.
DOI: 10.6084/m9.figshare.30577688
title: Figure 5G primary data

description: Figure 5G legend. KSHV-negative<b> </b>BJAB cells were treated with vehicle, 20 ng/ml TPA and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hrs. Protein was isolated and stained for ATF2 and β-actin as a loading control.
DOI: 10.6084/m9.figshare.30577688.v1
title: Figure 5G primary data

description: Figure 5G legend. KSHV-negative<b> </b>BJAB cells were treated with vehicle, 20 ng/ml TPA and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hrs. Protein was isolated and stained for ATF2 and β-actin as a loading control.
DOI: 10.6084/m9.figshare.30577115
title: Figure 4A primary data

description: Figure 4A legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to “untreated” lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment.
DOI: 10.6084/m9.figshare.30577115.v1
title: Figure 4A primary data

description: Figure 4A legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to “untreated” lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment.
DOI: 10.6084/m9.figshare.30577130
title: Figure 4B primary data

description: Figure 4B legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to “untreated” lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment.
DOI: 10.6084/m9.figshare.30577130.v1
title: Figure 4B primary data

description: Figure 4B legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to “untreated” lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment.
DOI: 10.6084/m9.figshare.30560777
title: Figure 3D-E primary data

description: Figure 3D-E legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In D<b>,</b> IFN-λ1 mRNA levels are plotted relative to the lytic+casp-i+anti-IFN Abs sample. The lytic+casp-i+anti-IFN Abs samples in E were sorted based on tdTomato expression and the fold enrichment in IFN-λ1 mRNA levels compared to unsorted (“bulk”) samples are plotted.
DOI: 10.6084/m9.figshare.30560777.v1
title: Figure 3D-E primary data

description: Figure 3D-E legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In D<b>,</b> IFN-λ1 mRNA levels are plotted relative to the lytic+casp-i+anti-IFN Abs sample. The lytic+casp-i+anti-IFN Abs samples in E were sorted based on tdTomato expression and the fold enrichment in IFN-λ1 mRNA levels compared to unsorted (“bulk”) samples are plotted.
DOI: 10.6084/m9.figshare.30560852
title: Figure 3F-G primary data

description: Figure 3F-G legend, BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. MxA mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In F<b>,</b> MxA mRNA levels are plotted relative to the lytic+casp-i sample. The lytic+casp-i samples in G were sorted based on tdTomato expression and the fold enrichment in MxA mRNA levels compared to unsorted (“bulk”) samples are plotted in log<sub>2</sub> scale.
DOI: 10.6084/m9.figshare.30560852.v1
title: Figure 3F-G primary data

description: Figure 3F-G legend, BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. MxA mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In F<b>,</b> MxA mRNA levels are plotted relative to the lytic+casp-i sample. The lytic+casp-i samples in G were sorted based on tdTomato expression and the fold enrichment in MxA mRNA levels compared to unsorted (“bulk”) samples are plotted in log<sub>2</sub> scale.
DOI: 10.6084/m9.figshare.30561236
title: Figure 3H-I primary data

description: Figure 3H-I BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. MxA mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In <b>H</b>, MxA mRNA levels are plotted relative to the lytic+casp-i+anti-IFN Abs sample. The lytic+casp-i+anti-IFN Abs in I samples were sorted based on tdTomato expression and the fold enrichment in MxA mRNA levels compared to unsorted (“bulk”) samples are plotted in log<sub>2</sub> scale.
DOI: 10.6084/m9.figshare.30561236.v1
title: Figure 3H-I primary data

description: Figure 3H-I BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. MxA mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In <b>H</b>, MxA mRNA levels are plotted relative to the lytic+casp-i+anti-IFN Abs sample. The lytic+casp-i+anti-IFN Abs in I samples were sorted based on tdTomato expression and the fold enrichment in MxA mRNA levels compared to unsorted (“bulk”) samples are plotted in log<sub>2</sub> scale.
DOI: 10.6084/m9.figshare.30559919
title: Figure 2C primary data

description: Figure 2C legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30559994
title: Figure 2D primary data

description: Figure 2D legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. Cells were stained for KSHV ORF45 and analyzed by flow cytometry
DOI: 10.6084/m9.figshare.30559994.v1
title: Figure 2D primary data

description: Figure 2D legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. Cells were stained for KSHV ORF45 and analyzed by flow cytometry
DOI: 10.6084/m9.figshare.30560006
title: Figure 2E primary data

description: Figure 2E-F legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. For E, mRNA levels are plotted relative to the lytic sample. For F, mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30560006.v1
title: Figure 2E primary data

description: Figure 2E-F legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. For E, mRNA levels are plotted relative to the lytic sample. For F, mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30560507
title: Figure 3B-C primary data

description: Figure 3B-C legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In B, IFN-λ1 mRNA levels are plotted relative to the lytic+casp-i sample. The lytic+casp-i samples in C were sorted based on tdTomato expression and the fold enrichment in IFN-λ1 mRNA levels compared to unsorted (“bulk”) samples are plotted.
DOI: 10.6084/m9.figshare.30560507.v1
title: Figure 3B-C primary data

description: Figure 3B-C legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In B, IFN-λ1 mRNA levels are plotted relative to the lytic+casp-i sample. The lytic+casp-i samples in C were sorted based on tdTomato expression and the fold enrichment in IFN-λ1 mRNA levels compared to unsorted (“bulk”) samples are plotted.
DOI: 10.6084/m9.figshare.30546740
title: Figure 1G primary data

description: Figure 1G-H legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In G, mRNA levels are<b> </b>plotted relative to the lytic sample. In H, mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546764
title: Figure 1H primary data

description: KSHV-negative BJAB cells were treated with 20 ng/mL TPA for 48 hours. Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). BC3 cells treated with 20 ng/mL TPA and 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) were used as a positive control. IFN-β and IFN-<b> </b>λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. They are plotted relative to the BC3 positive control
DOI: 10.6084/m9.figshare.30546764.v1
title: Figure 1H primary data

description: KSHV-negative BJAB cells were treated with 20 ng/mL TPA for 48 hours. Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). BC3 cells treated with 20 ng/mL TPA and 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) were used as a positive control. IFN-β and IFN-<b> </b>λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. They are plotted relative to the BC3 positive control
DOI: 10.6084/m9.figshare.30546779
title: Figure 1I primary data

description: KSHV-negative BJAB cells were treated with 20 ng/mL TPA for 48 hours. Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). BC3 cells treated with 20 ng/mL TPA and 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) were used as a positive control. IFN-β and IFN-<b> </b>λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. They are plotted relative to the BC3 positive control
DOI: 10.6084/m9.figshare.30546779.v1
title: Figure 1I primary data

description: KSHV-negative BJAB cells were treated with 20 ng/mL TPA for 48 hours. Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). BC3 cells treated with 20 ng/mL TPA and 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) were used as a positive control. IFN-β and IFN-<b> </b>λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. They are plotted relative to the BC3 positive control
DOI: 10.6084/m9.figshare.30559910
title: Figure 2A-B primary data

description: Figure 2A-B legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30559910.v1
title: Figure 2A-B primary data

description: Figure 2A-B legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30559919.v1
title: Figure 2C primary data

description: Figure 2C legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) and a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546710
title: Figure 1C-D primary data

description: Figure 1C legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546710.v1
title: Figure 1C-D primary data

description: Figure 1C legend. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546716
title: Figure 1E primary data

description: Figure 1E legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546716.v1
title: Figure 1E primary data

description: Figure 1E legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.6084/m9.figshare.30546728
title: Figure 1F primary data

description: Figure 1F legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). Cells were stained for the KSHV lytic protein ORF45 and the number of ORF45+ cells was measured by flow cytometry to assess reactivation.
DOI: 10.6084/m9.figshare.30546728.v1
title: Figure 1F primary data

description: Figure 1F legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). Cells were stained for the KSHV lytic protein ORF45 and the number of ORF45+ cells was measured by flow cytometry to assess reactivation.
DOI: 10.6084/m9.figshare.30546740.v1
title: Figure 1G primary data

description: Figure 1G-H legend - BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/mL TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). IFN-β, tdTomato, and ORF50 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. In G, mRNA levels are<b> </b>plotted relative to the lytic sample. In H, mRNA levels are plotted relative to the lytic+casp-i sample.
DOI: 10.5281/zenodo.18475498
title: Failure Statistics of Single-Particle Chains: Raw Data
DOI: 10.5281/zenodo.18475497
title: Failure Statistics of Single-Particle Chains: Raw Data
DOI: 10.6084/m9.figshare.30577238
title: Figure 4M primary data

description: Figure 4I legend. KSHV-negative<b> </b>BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3, and total IRF3.
DOI: 10.6084/m9.figshare.30577238.v1
title: Figure 4M primary data

description: Figure 4I legend. KSHV-negative<b> </b>BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3, and total IRF3.
DOI: 10.15468/dl.4se7bs
title: Occurrence Download

description: A dataset containing 1175555 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Spatula cyanoptera"
 ]
}

 The dataset includes 1175555 records from 239 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010782-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.